Nanoparticles and targeted drug delivery in cancer therapy
Behdokht Bahrami(Tabriz University of Medical Sciences), Farhad Jadidi‐Niaragh(Tabriz University of Medical Sciences), Ghasem Ghalamfarsa(Yasuj University of Medical Sciences), Mehdi Yousefi(Tabriz University of Medical Sciences), Mohammad Hojjat‐Farsangi(Karolinska University Hospital), Hamed Mohammadi(Tehran University of Medical Sciences), Enayat Anvari(Medical University of Ilam)
Cited by 507
Related Papers
The significant role of interleukin-6 and its signaling pathway in the immunopathogenesis and treatment of breast cancer
|Biomedicine & Pharmacotherapy|2018|312
The paradox of Th17 cell functions in tumor immunity
|Cellular Immunology|2017|222
Small-Molecule Inhibitors of the Receptor Tyrosine Kinases: Promising Tools for Targeted Cancer Therapies
|International Journal of Molecular Sciences|2014|202
A role for Th1-like Th17 cells in the pathogenesis of inflammatory and autoimmune disorders
|Molecular Immunology|2018|194
CDK1 in Breast Cancer: Implications for Theranostic Potential
|Anti-Cancer Agents in Medicinal Chemistry|2020|169